Scribe Therapeutics Inc. (SCTX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-08-03
4:37 pm
Purchase
2026-07-2713GScribe Therapeutics Inc.
SCTX
RA Capital Management, L.P.1,802,178
9.600%
1,802,178increase
(New Position)
Filing
History
2026-07-30
9:30 pm
Purchase
2026-07-2413DScribe Therapeutics Inc.
SCTX
Avoro Capital Advisors LLC3,088,888
16.370%
3,088,888increase
(New Position)
Filing
History
2026-07-30
4:39 pm
Purchase
2026-07-2313DScribe Therapeutics Inc.
SCTX
ELI LILLY & Co
LLY
1,388,161
7.300%
1,388,161increase
(New Position)
Filing
History
2026-07-29
6:42 pm
Purchase
2026-07-2713DScribe Therapeutics Inc.
SCTX
ORBIMED ADVISORS LLC1,348,825
7.200%
1,348,825increase
(New Position)
Filing
History